Funding Rounds
eXmoor Pharma

eXmoor Pharma Series A (2023, $35M)

eXmoor Pharma

End-to-end cell and gene therapy (CGT) manufacturer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $35.00M